ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Production of Avigan® Tablet (favipiravir) accelerated for use against COVID-19
April 20, 2020FUJIFILM intends to accelerate production of Avigan to 100,000 treatment courses per month by July and up to 300,000 by September 2020 to meet demand for possible use treating COVID-19. -
Fujifilm boosts production capacity for potential Covid-19 drug Avigan
April 17, 2020Japan’s Fujifilm has expanded manufacturing capacity to boost production of its influenza drug Avigan (favipiravir), being assessed to potentially treat Covid-19. -
Influenza antiviral Avigan® (favipiravir) to enter Phase III trials in COVID-19 patients
April 06, 2020The developers of Avigan have increased production and announced a Phase III clinical trial testing its efficacy against COVID-19. -
Chinese official says Fujifilm’s Favipiravir could treat Covid-19
March 19, 2020China’s Science and Technology Ministry official Zhang Xinmin has said that Japan-based Fujifilm’s anti-flu drug Favipiravir helped Covid-19 patients recover.
Pharma Sources Insight January 2025
